These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8745578)
1. Expression of p53 gene in oral squamous cell carcinoma and its relation with clinical and pathological parameters and prognosis of patients. Mao C; Lu Y; Lai Q; Xia Y; Yang C Chin Med Sci J; 1995 Dec; 10(4):199-203. PubMed ID: 8745578 [TBL] [Abstract][Full Text] [Related]
2. [Expression of p53 gene in oral squamous cell carcinoma and its relations with clinical and pathological parameters and prognosis of patients]. Mao C; Lu Y; Lai Q; Xia Y; Yang C Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Aug; 18(4):257-62. PubMed ID: 9388973 [TBL] [Abstract][Full Text] [Related]
3. The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma. Yang L; Wang Y; Guo L; Wang L; Chen W; Shi B Biomed Res Int; 2015; 2015():637853. PubMed ID: 26523280 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma. Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356 [TBL] [Abstract][Full Text] [Related]
5. [P53 expression and clinical significance in oral squamous cell carcinoma]. Long Y; Ling D; Yue W Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Shintani S; Yoshihama Y; Emilio AR; Matsumura T Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998 [TBL] [Abstract][Full Text] [Related]
8. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231 [TBL] [Abstract][Full Text] [Related]
9. The role of p300 in the tumor progression of oral squamous cell carcinoma. Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636 [TBL] [Abstract][Full Text] [Related]
11. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis]. Zhang T; Lai Q; Du D Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896 [TBL] [Abstract][Full Text] [Related]
12. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma. Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700 [TBL] [Abstract][Full Text] [Related]
13. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related]
14. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865 [TBL] [Abstract][Full Text] [Related]
15. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium. Ichikawa M; Ishii K; Nakajima T; Mogi K J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738 [TBL] [Abstract][Full Text] [Related]
16. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis. Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma. Ma HL; Jin SF; Tao WJ; Zhang ML; Zhang ZY J Craniomaxillofac Surg; 2016 Oct; 44(10):1725-1732. PubMed ID: 27591090 [TBL] [Abstract][Full Text] [Related]
18. [Detection of HPV type 16, 18 infection and p53 protein overexpression in oral squamous cell carcinoma]. Minawaer ; Ahmatjan A; Suzuk L Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):451-3. PubMed ID: 11930724 [TBL] [Abstract][Full Text] [Related]
19. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. de Oliveira LR; Ribeiro-Silva A; Zucoloto S J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]